Commentary: The ETP-based APC resistance assay remains the gold standard for evaluating the APC resistance phenotype in users of combined oral contraceptives
Saved in:
Main Authors: | Laure Morimont, Jonathan Douxfils |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1611404/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ABERRANT METHYLATION OF THE PROMOTER OF APC, CDH13 AND MGMT GENES IN COLORECTAL CANCER PATIENTS
by: O. I. Kit, et al.
Published: (2016-07-01) -
First case report: near early T-cell precursor acute lymphoblastic leukemia with plasmacytoid dendritic cell proliferation effectively treated with Venetoclax plus HAG regimen
by: Jiongping Han, et al.
Published: (2025-12-01) -
rSNP_Guide-BASED EVALUATION OF SNPs IN PROMOTеRS OF THE HUMAN APC AND MLH1 GENES ASSOCIATED WITH COLON CANCER
by: D. A. Rasskazov, et al.
Published: (2015-01-01) -
Heparin prophylaxis of gestational complications in women with Factor V Leiden mutation (GA genotype)
by: M. G. Nikolaeva, et al.
Published: (2018-08-01) -
HORMONAL CONTRACEPTION AND MAGNESIUM DEFICIENCY: A SUBANALYSIS OF THE MAGYN STUDY
by: D. V. Blinov, et al.
Published: (2017-06-01)